New England Asset Management’s Novartis NVS Stock Holding History
Bought
Maintained
Sold
Other funds holding NVS
New England Asset Management's NVS Position: Q1 2022 in Review
New England Asset Management sold out of Novartis (NVS) in Q1 2022, closing a stake of 850 shares — an estimated $74K sold.
New England Asset Management first reported a position in NVS in Q1 2015 and held it in 28 quarters. The position peaked at $259K in Q4 2016. 1,136 funds tracked by Wall St. Rank hold NVS as of Q1 2022.
- New England Asset Management reported no remaining Novartis position as of Q1 2022 after selling out during the quarter.
- New England Asset Management sold 850 Novartis shares in Q1 2022, an estimated $74K.
- New England Asset Management first reported a position in Novartis in Q1 2015 and held it in 28 quarters.
- New England Asset Management's Novartis position peaked at $259K in Q4 2016.
- 1,136 funds tracked by Wall St. Rank held Novartis as of Q1 2022.
Based on New England Asset Management's 13F filing for Q1 2022, filed 16 May 2022.